The Latest Breaking News from Obesity

Amgen stock slumped Monday — as Eli Lilly stock hit a record high — after the company unveiled preclinical results for its weight-loss drug.

Drug manufacturer Amgen Inc. (AMGN) is actively pursuing strategic collaborations and making noteworthy strides in the realm of obesity treatments. With the company all set to lift the curtains on its fiscal fourth-quarter earnings tomorrow, would it be prudent to take a bullish stance on the stock now? Keep reading…

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.

Nationwide says housing market looks ‘more positive’ as prices rise 0.7%; the Danish maker of Ozempic and Wegovy predicts further strong growth in 2024

Researchers found that when mothers take supplements with probiotics, myoinositol and vitamins B2, B6, B12 and D before giving birth, their children have less rapid weight gain and obesity by the age of 2.

While lifestyle variables such as nutrition and exercise contribute to the development and progression of obesity, scientists have shown that obesity is also linked to intrinsic metabolic abnormalities. Read further on Dynamite News:

Experts say alarming projections stem from surge in obesity, poor diets and physical inactivity

Do artificial sweeteners encourage bloating, raise insulin levels and encourage obesity? We asked the experts